Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 09, 2021

SELL
$105.44 - $127.98 $632 - $767
-6 Closed
0 $0
Q1 2021

May 07, 2021

BUY
$99.98 - $123.89 $599 - $743
6 New
6 $1,000
Q1 2020

May 12, 2020

SELL
$64.99 - $88.5 $29,960 - $40,798
-461 Closed
0 $0
Q4 2019

Feb 07, 2020

SELL
$54.2 - $75.03 $32.1 Million - $44.4 Million
-592,051 Reduced 99.92%
461 $35,000
Q3 2019

Nov 12, 2019

SELL
$52.55 - $63.28 $9.49 Million - $11.4 Million
-180,499 Reduced 23.35%
592,512 $33.8 Million
Q2 2019

Aug 12, 2019

BUY
$43.42 - $57.79 $33.1 Million - $44.1 Million
763,461 Added 7994.36%
773,011 $43.5 Million
Q1 2019

May 13, 2019

SELL
$49.95 - $59.21 $249,750 - $296,050
-5,000 Reduced 34.36%
9,550 $518,000
Q4 2018

Feb 11, 2019

BUY
$48.73 - $76.08 $292,380 - $456,480
6,000 Added 70.18%
14,550 $749,000
Q3 2018

Nov 08, 2018

SELL
$66.51 - $74.55 $399,060 - $447,300
-6,000 Reduced 41.24%
8,550 $612,000
Q1 2018

May 08, 2018

BUY
$65.0 - $80.03 $195,000 - $240,090
3,000 Added 25.97%
14,550 $959,000
Q4 2017

Feb 09, 2018

BUY
$53.89 - $72.36 $622,429 - $835,758
11,550
11,550 $834,000

Others Institutions Holding DVA

About DAVITA INC.


  • Ticker DVA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 91,300,000
  • Market Cap $15.1B
  • Description
  • DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine lab...
More about DVA
Track This Portfolio

Track Thompson Siegel & Walmsley LLC Portfolio

Follow Thompson Siegel & Walmsley LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.